HATBORO, Pa., March 15 /PRNewswire-FirstCall/ -- InfoLogix, Inc. , a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it received a letter, dated March 9, 2010, from the Nasdaq Stock Market notifying it that InfoLogix is not in compliance with NASDAQ's audit committee requirements under Listing Rule 5605. As a result of Wayne Hoch's resignation from the Company's Board of Directors and the audit committee of the Board of Directors on February 17, 2010, the audit committee has only two members rather than the required three and the Company cannot certify that the audit committee has at least one member with the requisite level of financial sophistication.
NASDAQ has provided InfoLogix with a cure period in order to regain compliance as follows: (i) until the earlier of InfoLogix's next annual stockholders' meeting or February 17, 2011, or (ii) if the next annual stockholders' meeting is held before August 16, 2010, then InfoLogix must evidence compliance no later than August 16, 2010. InfoLogix currently expects to regain compliance within the available cure period.
InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company .
Safe Harbor
Photo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.comInfoLogix, Inc.
